Serial measurements of lymphocytes, D-dimer, LDH, and CRP do not improve the ability to predict COVID-19 adverse outcomes.
Jorge Pulido-ArenasDaniela Saa-GonzálezOscar Mauricio Muñoz-VelandiaAlejandra Cañas-ArboledaPublished in: The Journal of international medical research (2023)
Measuring serum risk markers upon hospital admission can be used to evaluate risk of adverse outcomes in hospitalized patients with COVID-19. Repeating these measurements at 48 to 72 hours does not improve discriminatory ability.